Anhui Wanbang Pharmaceutical Technology Co.,Ltd. (SHE:301520)
China flag China · Delayed Price · Currency is CNY
41.83
-4.08 (-8.89%)
At close: Aug 3, 2026

SHE:301520 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
58150.3179.29253.5186.35161.55
Trading Asset Securities
1,0831,0011,023902.81--
Cash & Short-Term Investments
1,1411,1511,2031,156186.35161.55
Cash Growth
-1.48%-4.30%4.02%520.52%15.35%34.61%
Accounts Receivable
186.36191.52176.48135.0992.6857.88
Other Receivables
3.282.073.993.24--
Receivables
189.64193.59180.47138.3392.6857.88
Inventory
1.320.871.960.670.440.18
Other Current Assets
19.3814.6817.5466.886.756.36
Total Current Assets
1,3511,3601,4031,362286.22225.97
Property, Plant & Equipment
204.84200.64176.43150.0197.2842.15
Long-Term Investments
-243---
Other Intangible Assets
9.719.9211.571210.099.48
Long-Term Deferred Tax Assets
0.080.03-0.111.351
Long-Term Deferred Charges
0.950.852.759.585.393.16
Other Long-Term Assets
34.276.947.3210.74.281.88
Total Assets
1,6011,6031,6041,545404.6283.63

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
28.3133.4237.8327.027.864.75
Accrued Expenses
5.437.1813.9515.5915.9511.68
Short-Term Debt
2.421.61.61--
Current Portion of Leases
----0.030.12
Current Income Taxes Payable
0.660.060.270.311.673.62
Current Unearned Revenue
27.6119.0819.720.6517.6416.54
Other Current Liabilities
1.154.091.362.3622.17.57
Total Current Liabilities
65.5865.4474.7266.9465.2444.26
Long-Term Leases
-----0.03
Long-Term Unearned Revenue
9.459.97.416.552.942.95
Long-Term Deferred Tax Liabilities
5.246.798.317.14.83.51
Other Long-Term Liabilities
55----
Total Liabilities
85.2887.1390.4480.5872.9850.75

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
66.6766.6766.6766.675050
Additional Paid-In Capital
1,0391,0391,0371,03729.7929.79
Retained Earnings
425.09425.35412.12359.92251.83153.1
Treasury Stock
-15.23-15.23-2.84---
Total Common Equity
1,5161,5151,5131,464331.62232.88
Shareholders' Equity
1,5161,5151,5131,464331.62232.88
Total Liabilities & Equity
1,6011,6031,6041,545404.6283.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
2.421.61.610.030.15
Net Cash (Debt)
1,1381,1491,2011,155186.32161.41
Net Cash Growth
-1.54%-4.31%3.97%520.08%15.43%34.49%
Net Cash Per Share
12.2312.4012.8415.272.662.31
Filing Date Shares Outstanding
92.7792.7793.3393.337069.89
Total Common Shares Outstanding
92.7792.7793.3393.337069.89
Working Capital
1,2851,2951,3281,295220.97181.71
Book Value Per Share
16.3416.3416.2115.694.743.33
Tangible Book Value
1,5061,5051,5021,452321.52223.4
Tangible Book Value Per Share
16.2316.2316.0915.564.593.20
Buildings
-94.194.190.518.958.95
Machinery
-121.49117.6283.2449.0336.97
Construction In Progress
-36.971.67-56.939.16